ADPT: Adaptive Biotechnologies Corp.
About
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Current Value
$4.421 Year Return
Current Value
$4.421 Year Return
Key Details
Market Cap
$661.15M
P/E Ratio
-3.35
1Y Stock Return
6.16%
1Y Revenue Growth
-1.34%
Dividend Yield
0.00%
Price to Book
3.0
Strategies that include ADPT
Stock's related to ADPT
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TECH | 53.54% | $10.55B | +4.49% | 0.48% |
| CWH | 52.66% | $1.36B | +5.90% | 2.22% |
| ABCL | 52.59% | $800.44M | -37.56% | 0.00% |
| VIR | 51.68% | $954.40M | -26.51% | 0.00% |
| DDD | 51.25% | $402.06M | -35.13% | 0.00% |
| CERS | 50.28% | $312.00M | -0.59% | 0.00% |
| PACB | 50.20% | $471.05M | -79.23% | 0.00% |
| W | 49.83% | $5.11B | -15.44% | 0.00% |
| BEAM | 49.29% | $2.09B | -9.52% | 0.00% |
| SFIX | 49.06% | $480.74M | +11.14% | 0.00% |
| CAC | 48.95% | $676.24M | +38.60% | 3.63% |
| OPEN | 48.19% | $1.14B | -31.62% | 0.00% |
| RDFN | 47.50% | $1.01B | +24.16% | 0.00% |
| MCFT | 47.34% | $344.65M | -0.29% | 0.00% |
| WASH | 47.28% | $628.84M | +39.42% | 5.76% |
| AZTA | 47.22% | $2.00B | -28.24% | 0.00% |
| RVTY | 47.19% | $13.38B | +23.61% | 0.26% |
| TXG | 46.95% | $1.64B | -68.30% | 0.00% |
| ILMN | 46.91% | $21.41B | +44.38% | 0.00% |
| GPRO | 46.89% | $179.52M | -67.23% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ADBE | 0.03% | $219.93B | -18.23% | 0.00% |
| CCEC | 0.11% | $1.02B | +28.03% | 3.26% |
| WRB | -0.12% | $22.94B | +29.98% | 0.69% |
| MASI | -0.21% | $8.75B | +73.22% | 0.00% |
| NFLX | -0.24% | $372.45B | +83.46% | 0.00% |
| PRPH | 0.26% | $18.14M | -82.61% | 0.00% |
| UNM | 0.32% | $13.16B | +69.20% | 2.16% |
| OCX | 0.39% | $42.93M | -36.09% | 0.00% |
| STG | -0.45% | $35.67M | +7.92% | 0.00% |
| COST | -0.46% | $412.13B | +62.81% | 0.49% |
| ALAR | -0.58% | $89.09M | +158.08% | 0.00% |
| FWONK | 0.82% | $20.20B | +25.99% | 0.00% |
| IBKR | 0.83% | $20.20B | +131.83% | 0.37% |
| BACK | 0.92% | $1.76M | -32.90% | 0.00% |
| CYCN | 0.98% | $4.77M | -16.19% | 0.00% |
| RLMD | 1.01% | $89.92M | +1.36% | 0.00% |
| FATBB | 1.05% | $81.94M | -12.91% | 11.69% |
| ERIE | 1.06% | $19.39B | +46.23% | 1.23% |
| UNH | 1.07% | $531.00B | +6.93% | 1.37% |
| CHKP | -1.08% | $19.20B | +20.74% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | -24.54% | $78.15B | +35.51% | 0.42% |
| PGR | -17.69% | $149.10B | +57.29% | 0.45% |
| ACGL | -14.87% | $36.00B | +16.84% | 0.00% |
| COR | -14.14% | $47.48B | +21.20% | 0.86% |
| RNR | -13.99% | $13.74B | +23.09% | 0.58% |
| AJG | -12.96% | $64.17B | +17.51% | 0.80% |
| RSG | -12.35% | $66.05B | +31.79% | 1.04% |
| MMC | -11.53% | $108.41B | +10.89% | 1.37% |
| CAH | -9.74% | $28.64B | +12.14% | 1.70% |
| MNOV | -9.41% | $93.19M | +2.15% | 0.00% |
| KR | -8.75% | $42.03B | +35.08% | 2.11% |
| OXBR | -8.52% | $19.05M | +178.18% | 0.00% |
| VIST | -8.03% | $4.75B | +67.10% | 0.00% |
| MNR | -7.85% | $1.66B | -10.71% | 15.90% |
| CHD | -7.60% | $27.18B | +19.50% | 1.03% |
| TCTM | -7.19% | $8.10M | -42.99% | 0.00% |
| NHTC | -7.19% | $61.83M | +0.19% | 14.81% |
| WM | -6.93% | $87.92B | +27.58% | 1.34% |
| BTCT | -6.69% | $42.61M | +353.33% | 0.00% |
| CME | -6.63% | $82.76B | +9.21% | 1.98% |
ETF's related to ADPT
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ARKG | 68.13% | $1.13B | 0.75% |
| GNOM | 58.71% | $70.59M | 0.5% |
| IJS | 56.56% | $7.37B | 0.18% |
| VIOV | 56.47% | $1.44B | 0.15% |
| PRFZ | 56.34% | $2.65B | 0.39% |
| SLYV | 56.29% | $4.16B | 0.15% |
| IWC | 56.22% | $933.99M | 0.6% |
| MDYV | 56.16% | $3.25B | 0.15% |
| DFSV | 56.12% | $4.16B | 0.31% |
| XSHD | 55.96% | $54.49M | 0.3% |
| ESML | 55.94% | $1.90B | 0.17% |
| EDOC | 55.79% | $40.86M | 0.68% |
| IJR | 55.73% | $90.05B | 0.06% |
| EZM | 55.69% | $823.84M | 0.38% |
| KOMP | 55.68% | $2.09B | 0.2% |
| XRT | 55.55% | $451.85M | 0.35% |
| SPSM | 55.46% | $12.72B | 0.03% |
| IWN | 55.38% | $13.17B | 0.24% |
| IWM | 55.37% | $75.73B | 0.19% |
| SMLF | 55.37% | $1.44B | 0.15% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FBY | 0.01% | $127.69M | 0.99% |
| SOYB | 0.27% | $27.32M | 0.22% |
| ULST | -0.36% | $535.47M | 0.2% |
| AGZD | -0.44% | $142.76M | 0.23% |
| DBO | 0.90% | $217.57M | 0.77% |
| KCCA | 1.09% | $220.51M | 0.87% |
| CLOI | 1.10% | $715.40M | 0.4% |
| UNG | 1.12% | $908.80M | 1.06% |
| XHLF | 1.21% | $874.27M | 0.03% |
| HDRO | -1.42% | $164.26M | 0.3% |
| XBIL | 1.47% | $637.70M | 0.15% |
| WEAT | 1.47% | $120.27M | 0.28% |
| MINT | -1.63% | $11.62B | 0.35% |
| DFSD | 1.63% | $3.63B | 0.16% |
| CORN | -1.80% | $61.12M | 0.2% |
| CSHI | -2.03% | $482.85M | 0.38% |
| SHV | 2.13% | $18.13B | 0.15% |
| DBE | 2.25% | $50.13M | 0.77% |
| DBMF | -2.45% | $1.02B | 0.85% |
| CANE | 2.69% | $17.72M | 0.29% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -51.49% | $388.04M | 1.43% |
| USDU | -23.42% | $201.97M | 0.5% |
| UUP | -19.57% | $309.25M | 0.77% |
| VIXY | -18.98% | $195.31M | 0.85% |
| CTA | -13.67% | $350.27M | 0.78% |
| EQLS | -11.62% | $76.08M | 1% |
| DBA | -8.81% | $755.88M | 0.93% |
| TAIL | -8.24% | $67.98M | 0.59% |
| KMLM | -7.31% | $353.87M | 0.9% |
| JUCY | -6.96% | $324.29M | 0.6% |
| TBIL | -5.98% | $4.38B | 0.15% |
| IBHD | -5.97% | $327.80M | 0.35% |
| HIGH | -5.44% | $302.78M | 0.51% |
| JBBB | -4.97% | $1.26B | 0.49% |
| DBMF | -2.45% | $1.02B | 0.85% |
| CSHI | -2.03% | $482.85M | 0.38% |
| CORN | -1.80% | $61.12M | 0.2% |
| MINT | -1.63% | $11.62B | 0.35% |
| HDRO | -1.42% | $164.26M | 0.3% |
| AGZD | -0.44% | $142.76M | 0.23% |
News
Yahoo
The consensus price target hints at a 31.4% upside potential for Adaptive Biotechnologies (ADPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Yahoo
Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Yahoo
Adaptive Biotechnologies ( NASDAQ:ADPT ) Third Quarter 2024 Results Key Financial Results Revenue: US$46.4m (up 23...
Yahoo
Q3 2024 Adaptive Biotechnologies Corp Earnings Call
Yahoo
Adaptive Biotechnologies Corp (ADPT) reports a 22% revenue increase, driven by MRD growth, while managing cost reductions and strategic challenges.
Finnhub
Third Quarter 2024 Earnings Conference Call Safe Harbor This presentation has been prepared by Adaptive...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.